4//SEC Filing
Kawakami Mark 4
Accession 0000950170-25-014814
CIK 0001469443other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:34 PM ET
Size
5.4 KB
Accession
0000950170-25-014814
Insider Transaction Report
Form 4
Kawakami Mark
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-02-03$2.49/sh+700$1,743→ 2,681 total
Footnotes (2)
- [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock.
- [F2]The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeother
Related Parties
1- filerCIK 0002030709
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:34 PM ET
- Size
- 5.4 KB